P3 Health Partners (PIII) EBIAT: 2020-2025
Historic EBIAT for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to -$69.5 million.
- P3 Health Partners' EBIAT rose 3245.87% to -$69.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$286.6 million, marking a year-over-year decrease of 1445.73%. This contributed to the annual value of -$310.4 million for FY2024, which is 6650.04% down from last year.
- According to the latest figures from Q3 2025, P3 Health Partners' EBIAT is -$69.5 million, which was up 3245.87% from -$43.7 million recorded in Q2 2025.
- P3 Health Partners' 5-year EBIAT high stood at -$24.7 million for Q1 2021, and its period low was -$903.1 million during Q2 2022.
- Moreover, its 5-year median value for EBIAT was -$52.4 million (2023), whereas its average is -$124.3 million.
- In the last 5 years, P3 Health Partners' EBIAT plummeted by 296507.41% in 2022 and then surged by 9694.39% in 2023.
- Quarter analysis of 5 years shows P3 Health Partners' EBIAT stood at -$60.2 million in 2021, then plummeted by 783.9% to -$532.4 million in 2022, then surged by 87.02% to -$69.1 million in 2023, then tumbled by 86.91% to -$129.2 million in 2024, then skyrocketed by 46.19% to -$69.5 million in 2025.
- Its EBIAT stands at -$69.5 million for Q3 2025, versus -$43.7 million for Q2 2025 and -$44.2 million for Q1 2025.